{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:05Z","timestamp":1793831225000,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.yexcr.2025.114665","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:55:47Z","timestamp":1751421347000},"page":"114665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Timosaponin AIII alleviates type 2 diabetes-induced cardiomyopathy by targeting galectin-3 (LGALS3)"],"prefix":"10.1016","volume":"450","author":[{"given":"Jing","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114665_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.581902","article-title":"Abnormal neutrophil transcriptional signature may predict newly diagnosed latent autoimmune diabetes in adults of south China","volume":"11","author":"Xing","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2025.114665_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101357","article-title":"Prevalence of restless legs syndrome in people with diabetes mellitus: a pooling analysis of observational studies","volume":"46","author":"Ning","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114665_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1573403X15666191111123622","article-title":"Assessing cardiovascular risk in patients with diabetes: an update","volume":"16","author":"Damaskos","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114665_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"154910","key":"10.1016\/j.yexcr.2025.114665_bib5","first-page":"8","article-title":"Heart failure in diabetes","volume":"125","author":"Jankauskas","year":"2021","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114665_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/CM9.0000000000003075","article-title":"Mitochondrial energy metabolism in diabetic cardiomyopathy: physiological adaption, pathogenesis, and therapeutic targets","volume":"137","author":"Ye","year":"2024","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114665_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12933-020-01202-5","article-title":"Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114665_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052914","article-title":"Timosaponin A3 induces anti-obesity and anti-diabetic effects in vitro and in vivo","volume":"25","author":"Park","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114665_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.intimp.2015.02.016","article-title":"Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-\u03baB and MAPK activation and restoring Th17\/Treg cell balance","volume":"25","author":"Lim","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114665_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep38757","article-title":"Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor","volume":"6","author":"Cong","year":"2016","journal-title":"Sci. Rep."},{"issue":"155079","key":"10.1016\/j.yexcr.2025.114665_bib11","first-page":"12","article-title":"Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells","volume":"122","author":"Shen","year":"2024","journal-title":"Phytomedicine"},{"issue":"153247","key":"10.1016\/j.yexcr.2025.114665_bib12","article-title":"Timosaponin AIII attenuates inflammatory injury in AGEs-induced osteoblast and alloxan-induced diabetic osteoporosis zebrafish by modulating the RAGE\/MAPK signaling pathways","volume":"75","author":"Wang","year":"2020","journal-title":"Phytomedicine"},{"issue":"Pt 3","key":"10.1016\/j.yexcr.2025.114665_bib13","first-page":"11","article-title":"Anemarrhena asphodeloides bunge total saponins ameliorate diabetic cardiomyopathy by modifying the PI3K\/AKT\/HIF-1\u03b1 pathway to restore glycolytic metabolism","volume":"319","author":"Zhong","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114665_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020379","article-title":"Galectin-3: one molecule for an alphabet of diseases, from A to Z","volume":"19","author":"Sciacchitano","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114665_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbc.2022.102622","article-title":"Chimeric galectin-3 and collagens: biomarkers and potential therapeutic targets in fibroproliferative diseases","volume":"298","author":"Nangia-Makker","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114665_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jpi.12855","article-title":"Melatonin inhibits atherosclerosis progression via galectin-3 downregulation to enhance autophagy and inhibit inflammation","volume":"74","author":"Wang","year":"2023","journal-title":"J. Pineal Res."},{"issue":"7\u20139","key":"10.1016\/j.yexcr.2025.114665_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1023\/B:GLYC.0000014084.01324.15","article-title":"Galectin-3 and metastasis","volume":"19","author":"Takenaka","year":"2002","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.yexcr.2025.114665_bib18","article-title":"Insights into the role of Galectin-3 as a diagnostic and prognostic biomarker of atrial fibrillation","volume":"9","author":"Mohtasham Kia","year":"2023","journal-title":"Dis. Markers"},{"issue":"15","key":"10.1016\/j.yexcr.2025.114665_bib19","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/cvr\/cvad156","article-title":"Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy","volume":"119","author":"Frangogiannis","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2025.114665_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jvc.2023.06.003","article-title":"Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy","volume":"48","author":"Stack","year":"2023","journal-title":"J. Vet. Cardiol."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114665_bib21","article-title":"Prognosis value of galectin-3 in patients with dilated cardiomyopathy: a meta-analysis","volume":"23","author":"Xiong","year":"2024","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114665_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092153","article-title":"Role of circulating biomarkers in diabetic cardiomyopathy","volume":"12","author":"Iano\u015f","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114665_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11154-021-09704-7","article-title":"Emerging roles of Galectin-3 in diabetes and diabetes complications: a snapshot","volume":"23","author":"Li","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.yexcr.2025.114665_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.868372","article-title":"Galectin-3 inhibition ameliorates streptozotocin-induced diabetic cardiomyopathy in mice","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114665_bib25","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1139\/cjpp-2019-0708","article-title":"Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase\/reactive oxygen species pathway","volume":"98","author":"Sun","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114665_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11071379","article-title":"Inhibition of GCN2 alleviates cardiomyopathy in type 2 diabetic mice via attenuating lipotoxicity and oxidative stress","volume":"11","author":"Yuan","year":"2022","journal-title":"Antioxidants"},{"issue":"111361","key":"10.1016\/j.yexcr.2025.114665_bib27","first-page":"27","article-title":"Hinokinin alleviates high fat diet\/streptozotocin-induced cardiac injury in mice through modulation in oxidative stress, inflammation and apoptosis","volume":"137","author":"Lu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114665_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/j.2040-4603.2017.tb00752.x","article-title":"Pathophysiological fundamentals of diabetic cardiomyopathy","volume":"7","author":"Hu","year":"2017","journal-title":"Compr. Physiol."},{"issue":"21","key":"10.1016\/j.yexcr.2025.114665_bib29","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways","volume":"24","author":"Ren","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114665_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5603\/FHC.a2022.0030","article-title":"Astragaloside IV - mediated endothelial progenitor cell exosomes promote autophagy and inhibit apoptosis in hyperglycemic damaged endothelial cells via miR-21\/PTEN axis","volume":"60","author":"Xiong","year":"2022","journal-title":"Folia Histochem. Cytobiol."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114665_bib31","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s11010-024-04926-0","article-title":"TRPM2 knockdown attenuates myocardial apoptosis and promotes autophagy in HFD\/STZ-induced diabetic mice via regulating the MEK\/ERK and mTORC1 signaling pathway","volume":"479","author":"Hu","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"117427","key":"10.1016\/j.yexcr.2025.114665_bib32","first-page":"20","article-title":"Pharmacological properties of Ensete glaucum seed extract: novel insights for antidiabetic effects via modulation of oxidative stress, inflammation, apoptosis and MAPK signaling pathways","volume":"320","author":"Ly","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yexcr.2025.114665_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.907757","article-title":"Signaling pathways related to oxidative stress in diabetic cardiomyopathy","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2025.114665_bib34","article-title":"Oxidative stress signaling mediated pathogenesis of diabetic cardiomyopathy","volume":"22","author":"Tang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114665_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ejhf.231","article-title":"Oxidative myocardial damage in human cocaine-related cardiomyopathy","volume":"17","author":"Frustaci","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yexcr.2025.114665_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1011669","article-title":"Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy","volume":"13","author":"Du","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114665_bib37","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jcmm.14870","article-title":"Allopurinol reduces oxidative stress and activates Nrf2\/p62 to attenuate diabetic cardiomyopathy in rats","volume":"24","author":"Luo","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114665_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00894-018-3831-4","article-title":"Bergenin: a computationally proven promising scaffold for novel galectin-3 inhibitors","volume":"24","author":"Jayakody","year":"2018","journal-title":"J. Mol. Model."},{"issue":"14","key":"10.1016\/j.yexcr.2025.114665_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141846","article-title":"Targeted protein degradation: principles and applications of the proteasome","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114665_bib40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4239\/wjd.v12.i6.685","article-title":"Role of novel biomarkers in diabetic cardiomyopathy","volume":"12","author":"Kumric","year":"2021","journal-title":"World J. Diabetes"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114665_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33594\/000000220","article-title":"Galectin-3: a cardiomyocyte antiapoptotic mediator at 24-Hour post myocardial infarction","volume":"54","author":"Al-Salam","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yexcr.2025.114665_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.765591","article-title":"Spermidine affects cardiac function in heart failure mice by influencing the gut microbiota and cardiac Galectin-3","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"108602","key":"10.1016\/j.yexcr.2025.114665_bib43","first-page":"24","article-title":"Galectin-3 knock Down inhibits cardiac ischemia-reperfusion injury through interacting with bcl-2 and modulating cell apoptosis","volume":"694","author":"Zhang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114665_bib44","first-page":"4106","article-title":"Therapeutic inhibition of galectin-3 improves cardiomyocyte apoptosis and survival during heart failure","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"172701","key":"10.1016\/j.yexcr.2025.114665_bib45","first-page":"27","article-title":"Cardioprotective effects of galectin-3 inhibition against ischemia\/reperfusion injury","volume":"863","author":"Mo","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114665_bib46","first-page":"595","article-title":"Galectin-3 in patients with chronic heart failure: association with oxidative stress, inflammation, renal dysfunction and prognosis","volume":"64","author":"Medvedeva","year":"2016","journal-title":"Minerva Cardioangiol."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114665_bib47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1159\/000494539","article-title":"Myocardial ischemia reperfusion injury: apoptotic, inflammatory and oxidative stress role of Galectin-3","volume":"50","author":"Al-Salam","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"13","key":"10.1016\/j.yexcr.2025.114665_bib48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1042\/CS20171389","article-title":"Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage","volume":"132","author":"Ibarrola","year":"2018","journal-title":"Clin. Sci."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725002654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725002654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:21:10Z","timestamp":1777018870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725002654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0014482725002654"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114665","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timosaponin AIII alleviates type 2 diabetes-induced cardiomyopathy by targeting galectin-3 (LGALS3)","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114665"}}